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1. Introduction 
Permanent or transient damage with serious implications on 
adjacent organs and systems may be due to tissue ischemia - reperfusion 
(IR). The use of U-74389G in IR has been a challenge for many years. 
However, although the progress was significant, several practical 
questions have not clarified. They include: a) how potent U-74389G 
should be b) when should it be administered and c) at what optimal dose 
U-74389G should be administered. The promising effect of U-74389G in 
tissue protection has been noted in several IR studies. U-74389G or also 
known as 21-[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl]-
pregna-1,4,9(11)-triene-3,20-dione maleate salt is an antioxidant which 
prevents both arachidonic acid-induced and iron-dependent lipid 
peroxidation[1]. It protects against IR injury in animal organs such as 
heart, liver and kidney models. These membrane-associating 
antioxidants are particularly effective in preventing permeability 
changes in brain microvascular endothelial cells monolayers2. A meta-
analysis of 26 published seric variables, coming from the same 
experimental setting, tried to provide a numeric evaluation of the U-
74389G efficacy at the same endpoints (Table 1). Several publications 
addressed trials of other similar antioxidant molecules to which the 
studied molecule U-74389G belongs to.  
The aim of this experimental study was to examine the effect 
of the antioxidant drug “U-74389G” on rat model and particularly in a 
generalized adrenal ischemia - reperfusion (IR) protocol. The effects of 
that molecule were studied by measuring blood mean testosterone (T) 
levels. 
 
2. Materials and methods 
2.1 Animal preparation 
This basic experimental research was licensed by Veterinary 
Address of East Attiki Prefecture under 3693/12-11- 2010 & 14/10-1-
2012 decisions. All consumables, equipment and substances, were a 
grant of Experimental Research Centre of ELPEN Pharmaceuticals Co. 
Inc. S.A. at Pikermi, Attiki. Accepted standards of human animal care 
were adopted for Albino female Wistar rats. 7 days pre-experimental 
normal housing included ad libitum diet in laboratory. Prenarcosis of 
animals proceeded of continuous intra-experimental general anesthesia3-
5, oxygen supply, electrocardiogram and acidometry. Post-experimental 
euthanasia did not permitted awakening and preservation of the 
animals. Rats were randomly delivered to four experimental groups by 
10 animals in each one, using following protocols of IR: Ischemia for 45 
min followed by reperfusion for 60 min (group A); ischemia for 45 min 
followed by reperfusion for 120 min (group B); ischemia for 45 min 
followed by immediate U-74389G intravenous (IV) administration and 
reperfusion for 60 min (group C); ischemia for 45 min followed by 
immediate U-74389G IV administration and reperfusion for 120 min 
(group D). The dose of U-74389G was 10 mg/Kg body mass of animals. 
Ischemia was caused by laparotomic clamping inferior aorta over renal 
arteries with forceps for 45 min. The clamp removal restored the inferior 
aorta patency and reperfusion. U-74389G was administered at the time 
of reperfusion; through catheterized inferior vena cava. The T levels 
were determined at 60th min of reperfusion (for A and C groups) and at 
120th min of reperfusion (for B and D groups). Fourty female Wistar 
albino rats were used (mean weight 231.875 g [Standard Deviation (SD): 
36.59703 g], with minimum weight 165 g and maximum weight 320 g. 
Rats' weight could be potentially a confusing factor, e.g. more obese rats 
to have higher T levels. This assumption was also investigated. 
2.2 Model of ischemia reperfusion injury 
Control groups: 20 control rats of mean weight 252.5 g [SD: 39.31988 g] 
experienced ischemia for 45 min followed by reperfusion.  
Group A: Reperfusion which lasted 60 min concerned 10 control rats of 
mean weight 243 g [SD: 45.77724 g] and mean T levels 0.091 ng/ml [SD: 
0.0455705 ng/ml] (Table 2).       
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Group B: Reperfusion which lasted 120 min concerned 10 control rats of 
mean weight 262 g [SD: 31.10913 g] and mean T levels 0.034 ng/ml [SD: 
0.0084327 ng/ml] (Table 2).     
Lazaroid (L) group: 20 rats of mean weight 211.25 g [SD: 17.53755 g] 
experienced ischemia for 45 min followed by reperfusion in the 
beginning of which 10 mg U-74389G /kg body weight were IV 
administered.  
Group C: Reperfusion which lasted 60 min concerned 10 L rats of mean 
weight 212.5 g [SD: 17.83411 g] and mean T levels 0.137 ng/ml [SD: 
0.0851208 ng/ml] (Table 2).     
Group D: Reperfusion which lasted 120 min concerned 10 L rats of 
mean weight 210 g [SD: 18.10463 g] and mean T levels 0.066 ng/ml [SD: 
0.0648417 ng/ml] (Table 2).   
 
3. Results  
Every weight and T level group was compared with each other 
by statistical standard t-tests (Table 3). Any significant difference among 
T levels, was investigated whether owed in any potent significant weight 
one. The application of generalized linear models (glm) with dependant 
variable the T levels was followed. The 3 independent variables were the 
U-74389G or no drug administration, the reperfusion time and both 
variables in combination. Inserting the rats’ weight also as an 
independent variable at glm analysis, a non significant relation resulted 
in (p= 0.1741), so as to further investigation was not needed.  
The glm resulted in: U-74389G administration significantly 
increased the T levels by 0.039 ng/ml [-0.0030339 ng/ml - 0.0810339 
ng/ml] (p= 0.0680). This finding was in accordance with the results of 
standard t-test (p=0.0223). Reperfusion time significantly decreased the 
T levels by 0.064 ng/ml [-0.1025895 ng/ml - -0.0254105 ng/ml] (p= 
0.0018), in accordance also with standard t-test (P= 0.0021). However, 
U-74389G administration and reperfusion time together produced a 
non-significant combined effect in increasing the T levels by 0.0083636 
ng/ml [-0.0179916 ng/ml - 0.0347188 ng/ml] (p= 0.5245). Reviewing 
the above and table 3, the tables 4 and 5 sum up concerning the 
increasing influence of U-74389G along with reperfusion time.  
 
Table 1: The U-74389G influence (+SD) on the levels of some seric variables3 concerning reperfusion (rep) time 
 
Variable 1h rep p-value 1.5h rep p-value 2h rep p-value 
interaction of U-
74389G and rep 
p-value 
WBCC +22.99%+12.45% 0.0914 +30.85%+11.14% 0.0045 +38.70%+17.39% 0.0185 +23.45%+6.28% 0.0004 
RBCC   +1.39%+0.71% 0.7161 +0.64%+0.32% 0.8106 -0.10%+0.05% 0.9762 +1.05%+0.53% 0.4911 
Hematocrit +5.58%+3% 0.0852 +4.73%+2.25% 0.0435 +3.89%+3.44% 0.2608 +3.16%+1.33% 0.0196 
Hemoglobin +5.2%+2.8% 0.0925 +3.9%+2.1% 0.0604 +2.7%+3.2% 0.3544 +2.5%+1.3% 0.0423 
MCH +1.77%+0.96% 0.0663 +2.40%+0.57% 0.0001 +3.03%+0.71% 0.0003 1.33%+0.36% 0.0005 
MCV5 +2.12%+1.16% 0.0663 +2.88%+0.69% 0.0001 +3.64%+0.85% 0.0003 +1.6%+0.43% 0.0005 
MCHC -0.5%+0.74% 0.4820 -0.95%+0.63% 0.1124 -1.4%+1.12% 0.1603 -0.69%+0.37% 0.0655 
RbcDW -6.13%+3.73% 0.0667 -4.96%+2.27% 0.0175 -3.80%+3.07% 0.1383 -2.54%+1.39% 0.679 
Platelet count -17.79%+9.40% 0.0647 -12.83%+5.79% 0.0303 -7.88%+7.83% 0.2939 -6.12%+3.58% 0.0857 
Platelet-crit +3.80%+9.87% 0.6373 +9.23%+6.29% 0.1064 +14.66%+9.03% 0.0833 +6.72%+3.73% 0.0712 
PDW +1.1%+0.88% 0.2368 +1.79%+0.76% 0.0314 +2.49%+1.33% 0.0807 +0.96%+0.46% 0.0396 
Glucose -6.41%+3.50% 0.0663 -8.57%+2.06% 0.0001 -10.74%+2.52% 0.0003 -4.76%+1.28% 0.0005 
Creatinine -15.96%+8.71% 0.0663 -21.02%+5.06% 0.0001 -26.09%+6.12% 0.0003 -11.69%+3.16% 0.0005 
Uric acid +20.86%+14.44% 0.1614 +15.43%+9.10% 0.0960 +10%+12.11% 0.3946 +4.78%+5.64% 0.3873 
Total protein                -5.48%+2.99% 0.0663 -7.34%+1.76% 0.0000 -9.20%+2.16% 0.0000 -4.08%+1.10% 0.0000 
γGT +19.35%+18.58% 0.2362 +6.82%+14.89% 0.6442 -5.71%+20.10% 0.7809 +1.23%+9% 0.8877 
ALP  +22.66%+12.37% 0.0663 +31.91%+7.69% 0.0001 +41.16%+9.65% 0.0003 +17.75%+4.79% 0.0005 
ACP -112.54%+20.95% 0.0006 -128.45%+14.84% 0.0000 -144.36%+21.62% 0.0000 -74.45%+9.63% 0.0000 
CPK +54.32%+13.75% 0.0012 +35.34%+17.20% 0.0260 +16.37%+30.24% 0.4951 +18.52%+9.44% 0.0770 
LDH +13.56%+7.40% 0.0663 +18.78%+4.52% 0.0001 +24.01%+5.63% 0.0003 +10.43%+2.82% 0.0005 
Sodium   +1.22%+0.66% 0.0707 +0.17%+0.61% 0.7714 -0.87%+1.03% 0.3995 -0.32%+0.36% 0.3693 
Potassium4 -10.12%+4.82% 0.0579 -2.14%+5.06% 0.6730 +5.83%+6.79% 0.3801 +2.07%+3.03% 0.4853 
Chloride   -0.58%+0.77% 0.4533 -0.97%+0.53% 0.0879 -1.36%+0.76% 0.1113 -0.75%+0.38% 0.0159 
Calcium    0%+1.75% 1 -0.14%+1.10% 0.8782 -0.28%+1.54% 0.8492 +0.14%+0.64% 0.8245 
Phosphorus   -2.23%+5.51% 0.7966 -1.61%+3.32% 0.5789 -1%+4.48% 0.8129 -1.09%+2% 0.5771 
Magnesium +1.33%+3.59% 0.7033 -0.28%+2.75% 0.9171 -1.90%+5.28% 0.7161 +0.36%+4.58% 0.8228 
Mean -0.01%+27.22% 0.2468 -0.93%+29.14% 0.2265 -1.85%+32.36% 0.2810 -0.40%+16.94% 0.2286 
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Table 2: Weight and testosterone mean levels and Std. Dev. of 
groups 
Groups Variable Mean Std. Dev 
Α Weight 243 g 45.77724 g 
 Testosterone 0.091 ng/ml 0.0455705 ng/ml 
B Weight 262 g 31.10913 g 
 Testosterone 0.034 ng/ml 0.0084327 ng/ml 
C Weight 212.5 g 17.83411 g 
 Testosterone 0.137 ng/ml 0.0851208 ng/ml 
D Weight 210 g 18.10463 g 
 Testosterone 0.066 ng/ml 0.0648417 ng/ml 
Table 3: Statistical significance of mean values difference for groups 
(DG) after statistical standard t test application 
DG Variable Difference p-value 
Α-Β Weight -19 g 0.3555 
 Testosterone 0.057 ng/ml 0.0031 
Α-C                    Weight 30.5 g 0.0674 
 Testosterone -0.046 ng/ml 0.1030 
Α-D                    Weight 33 g 0.0574 
 Testosterone 0.025 ng/ml 0.2674 
Β-C Weight 49.5 g 0.0062 
 Testosterone -0.103 ng/ml 0.0043 
Β-D                    Weight 52 g 0.0009 
 Testosterone -0.032 ng/ml 0.1369 
C-D Weight 2.5 g 0.7043 
 Testosterone 0.071 ng/ml 0.0662 
 
Table 4: The increasing influence of U-74389G in connection with 
reperfusion time 
Increase 95% c. in 
Reperfusion 
time 
p-values 
   t-test glm 
0.046 ng/ml 
-0.018146 ng/ml 
-0.110146 ng/ml 
1h 0.1030 0.1493 
0.039 ng/ml 
-0.0030339 ng/ml 
- 0.0810339ng/ml 
1.5h 0.0223 0.0680 
0.032 ng/ml 
-0.0114416 ng/ml 
- 0.0754416ng/ml 
- 2h 0.1369 0.1391 
0.064 ng/ml 
-0.1025895 ng/ml 
-0.0254105 ng/ml 
reperfusion 
time 
0.0021 0.0018 
0.0083636 
ng/ml 
-0.0179916 ng/ml 
- 0.0347188ng/ml 
interaction - 
0.5245 
 
 
Table 5: The (%) increasing influence of U-74389G in connection 
with reperfusion time 
Increase +SD Reperfusion time p-values 
40.35% +28.70% 1h 0.1261 
52.17% +28.69% 1.5h 0.0451 
64% +44.32% 2h 0.1380 
-85.62% +26.33% reperfusion time 0.0019 
11.18% +17.97% interaction 0.5245 
 
4. Discussion 
T is considered a reliable index substance of adrenals 
metabolism; being of great clinical significance. Examples are described 
herein concerning whether adrenal ischemia can influence the T levels. 
Cakir E et al found [6] total T levels significantly higher in PCOS women 
also having higher risk for cardiovascular disease (CVD) and myocardial 
ischemia than control subjects. Guven S et al found [7] significantly 
higher concentrations of serum total T (P = 0.031), elevated serum 
ischemia-modified albumin (IMA) concentrations - a clinical marker of 
ongoing myocardial ischemia - well correlated with total T levels (P = 
0.022) in women with PCOS than control group. Shaw LJ et al [8] found 
more frequent and heavy angiographic coronary artery disease (CAD) (P 
= 0.04) and 9.8% less cumulative 5-yr cardiovascular (CV) event-free 
survival (P = 0.006) in women with clinical features of PCOS as defined 
by top T quartile (> 30.9 ng/dl) than normal control women. PCOS 
remained a significant predictor (P < 0.01) in prognostic models for 
suspected ischemia and CV disease. Kovalenko AN et al [9] determined 
peripheral blood T concentrations with consequences on metabolic 
background conducting to cerebral atherosclerosis and ischemic stroke 
development in clinically normal elderly than younger subjects. 
 
5. Conclusion 
U-74389G administration interacted or not with reperfusion 
time increased short – term the testosterone levels. The intervention of 
this molecule into the biosynthetic pathway of T worths further 
investigation.        
Acknowledgment: This study was funded by Scholarship by 
the Experimental Research Center ELPEN Pharmaceuticals (E.R.C.E), 
Athens, Greece. The research facilities for this project were provided by 
the aforementioned institution. 
 
References 
[1] https://www.caymanchem.com/app/template/Product.vm/catalo
g/75860. 
[2] Fenglin Shi, Jennifer Cavitt, Kenneth L Audus. 21-aminosteroid and 
2-(aminomethyl)chromans inhibition of arachidonic acid-induced 
lipid peroxidation and permeability enhancement in bovine brain 
microvessel endothelial cell monolayers. Free Radical Biology and 
Medicine, 1995; 19(3): 349-357. 
[3] Τsompos C, Panoulis C, Τοutouzas K, Triantafyllou A, Ζografos G, et 
al. The Effect of the Antioxidant Drug “U-74389G” on Lactate 
Dehydrogenase Levels during Ischemia Reperfusion Injury in Rats. J 
Anal Pharm Res 2016; 3(1): 00043. 
[4] Τsompos C., Panoulis C., Τοutouzas K., Ζografos G., Papalois A. 
The trends of the antioxidant drug “U-74389G” on potassium levels 
during hypoxia reoxygenation injury in rats. Periodicum 
Biologorum 2016; 118(2): 105–110. 
[5] Τsompos C, Panoulis C, Τοutouzas K, Triantafyllou A, Ζografos G, et 
al. The Acute Effect of the Antioxidant Drug “U-74389G” on Mean 
Corpuscular Volume Levels during Ischemia Reperfusion Injury in 
Rats. Research Journal of Pharmacology and Toxicology 2015; 
01[05]: 54-57. 
[6] Cakir E, Ozbek M, Sahin M, et al: Heart type fatty acid binding 
protein response and subsequent development of atherosclerosis 
in insulin resistant polycystic ovary syndrome patients. J Ovarian 
Res. 2012 Dec 18; 5(1):45.  
[7] Guven S, Karahan SC, Bayram C, et al: Elevated concentrations of 
serum ischaemia-modified albumin in PCOS, a novel ischaemia 
marker of coronary artery disease. Reprod Biomed Online. 2009 Oct; 
19(4):493-500. 
[8] Shaw LJ, Bairey Merz CN, Azziz R, et al: Postmenopausal women 
with a history of irregular menses and elevated androgen 
measurements at high risk for worsening cardiovascular event-free 
survival: results from the National Institutes of Health--National 
Heart, Lung, and Blood Institute sponsored Women's Ischemia 
Syndrome Evaluation. J Clin Endocrinol Metab. 2008 Apr; 
93(4):1276-84.  
[9] Kovalenko AN, Kostiuchenko VG. Gonadal and gonadotropic 
function of late middle-aged men and women with sequelae of 
ischemic stroke. Zh Nevropatol Psikhiatr Im S S Korsakova. 1987; 
87(1):29-33. 
